Opinion

Video

CAR T: A Review of Clinical Data for Second Line Treatments of Large B-Cell Lymphoma

Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.

Related Videos
1 expert in this video
1 expert in this video
Minoo Battiwalla, MD, MS
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.
2 KOLs are featured in this series.
2 KOLs are featured in this series.